Market By Application, Component, And Country | Forecast 2021-2028
As per Triton’s report, Europe’s precision medicine market is estimated to garner a CAGR of 9.86% in terms of revenue during the assessed years of 2021-2028.
The countries examined in this market include:
• The UK
• Spain
• Germany
• Italy
• France
• Russia
• Rest of Europe
Europe’s precision medicine market is growing at a tremendous rate, owing to the surging healthcare expenditure and rising focus on eliminating chronic diseases. Additionally, several government initiatives favoring precision medicine adoption are also anticipated to fuel the growth of the precision medicine market in the European region in the near future.
In Germany, personalized medicine is one of the high priorities in the Health Research Framework Program initiated by the federal government. For instance, the Federal Research Ministry has funded a substantial amount for precision medicine research and implementation. Such investments and research initiatives have aided the healthcare industry to explore the benefits of precision medicine for the country’s population. Hence, the growing government efforts to increase awareness relating to precision medicine implementation are anticipated to propel Germany’s precision medicine market towards the path of expansion.
On the other hand, the steps to increase precision medicine adoption have gained momentum across France. For instance, the country is playing a significant role in the development of precision medicine by offering human resources to conduct various clinical studies. Additionally, the government initiative, Genomic Medicine 2025, is likely to position France as one of the leaders in the genomic medicine segment in the next few years. Hence, as stated above, these factors are augmenting the evolution of the French precision medicine market.
AstraZeneca Plc is a biotechnology and pharmaceutical company focused on diagnostic technologies, including molecular diagnostics and next-generation sequencing. Besides, the company has an in-house center for genomics research that analyzes genomes, helping in the detection of new genetic causes for drug discovery and development. It has a broad consumer base, with headquarters set in the United Kingdom.
Market By Type, Application, E ..
VIEW REPORT
Market By Device Type, Therape ..
VIEW REPORT
Market By Type, Application, T ..
VIEW REPORT
Market By Technology, Applicat ..
VIEW REPORT
Market By Application, Type, E ..
VIEW REPORT
Market by Therapeutics, Diagno ..
VIEW REPORT
Market by Type, Application, E ..
VIEW REPORT
1. EUROPE PRECISION MEDICINE MARKET - SUMMARY
2. INDUSTRY OUTLOOK
2.1. KEY INSIGHTS
2.1.1. PRESENCE OF BIOPHARMACEUTICAL COMPANIES
2.1.2. INVESTMENTS IN GENE THERAPY
2.2. IMPACT OF COVID-19 ON PRECISION MEDICINE MARKET
2.3. SUPPLY CHAIN OUTLOOK
2.4. ETYMOLOGY OF PRECISION MEDICINE
2.5. PORTER’S FIVE FORCES MODEL
2.6. MARKET ATTRACTIVENESS INDEX
2.7. VENDOR LANDSCAPE
2.8. KEY MARKET STRATEGIES
2.8.1. CONTRACTS AND PARTNERSHIPS
2.8.2. BUSINESS EXPANSION & DIVESTITURES
2.8.3. ACQUISITIONS & MERGERS
2.8.4. NEW PRODUCT LAUNCHES
2.9. MARKET DRIVERS
2.9.1. HIGH PREVALENCE OF CHRONIC DISEASES IN THE AGING POPULATION
2.9.2. DIGITAL COLLABORATION AMONG RESEARCH GROUPS AND ORGANIZATIONS
2.9.3. IDENTIFICATION OF GENETIC MAKEUP IN THE HUMAN GENOME
2.10. MARKET CHALLENGES
2.10.1. STRINGENT DRUG APPROVAL PROCESS
2.10.2. SECURITY THREATS PERTAINING TO DATA SHARING
2.10.3. CHANGES IN REIMBURSEMENT AND REGULATORY PROCESS
2.11. MARKET OPPORTUNITIES
2.11.1. INVESTMENTS BY GOVERNMENT AND PRIVATE PLAYERS IN CANCER TREATMENT
2.11.2. DEMAND FOR PREVENTIVE CARE
3. EUROPE PRECISION MEDICINE MARKET - BY APPLICATION
3.1. ONCOLOGY
3.2. INFECTIOUS DISEASES
3.3. NEUROLOGY/PHYSIATRY
3.4. CARDIOVASCULAR
3.5. LIFESTYLE AND ENDOCRINOLOGY
3.6. GASTROENTEROLOGY
3.7. OTHER APPLICATIONS
4. EUROPE PRECISION MEDICINE MARKET - BY COMPONENT
4.1. APPLIED SCIENCE
4.1.1. GENOMICS
4.1.1.1. PCR
4.1.1.2. PM NGS
4.1.1.3. GENOME EDITING
4.1.1.4. OTHER GENOMICS TECHNOLOGIES
4.1.2. PHARMACOGENOMICS
4.1.3. OTHER APPLIED SCIENCES
4.2. PRECISION THERAPEUTICS
4.2.1. CLINICAL TRIALS
4.2.2. CELL THERAPY
4.2.3. DRUG DISCOVERY AND RESEARCH
4.2.4. GENE THERAPY
4.3. PRECISION DIAGNOSTICS
4.3.1. MOLECULAR DIAGNOSTICS
4.3.1.1. NON-INVASIVE PRENATAL TESTING (NIPT)
4.3.1.2. COMPANION DIAGNOSTICS
4.3.1.3. LIQUID BIOPSY
4.3.1.4. OTHER MOLECULAR DIAGNOSTICS
4.3.2. MEDICAL IMAGING
4.3.2.1. IMAGING ANALYTICS
4.3.2.2. IMAGING COMPUTER-AIDED DETECTION (CADX)
4.4. DIGITAL HEALTH AND INFORMATION TECHNOLOGY
4.4.1. CLINICAL DECISION SUPPORT SYSTEMS (CDSS)
4.4.2. BIG DATA ANALYTICS
4.4.3. IT INFRASTRUCTURE
4.4.4. GENOMICS INFORMATICS
4.4.5. IN-SILICO INFORMATICS
4.4.6. MOBILE HEALTH
5. EUROPE PRECISION MEDICINE MARKET – REGIONAL OUTLOOK
5.1. COUNTRY ANALYSIS
5.1.1. GERMANY
5.1.2. FRANCE
5.1.3. UNITED KINGDOM
5.1.4. ITALY
5.1.5. RUSSIA
5.1.6. SPAIN
5.1.7. REST OF EUROPE
6. COMPETITIVE LANDSCAPE
6.1. ABBOTT LABORATORIES
6.2. ASTRAZENECA PLC
6.3. BIOCRATES LIFE SCIENCES AG
6.4. BIO-RAD LABORATORIES INC
6.5. DANAHER CORPORATION
6.6. EAGLE GENOMICS LTD
6.7. ELI LILLY & COMPANY
6.8. F HOFFMANN-LA ROCHE AG
6.9. INTOMICS
6.10. LABORATORY CORPORATION OF AMERICA HOLDINGS
6.11. NANOSTRING TECHNOLOGIES
6.12. NOVARTIS AG
6.13. PFIZER INC
6.14. QIAGEN NV
6.15. QUEST DIAGNOSTICS INCORPORATED
7. RESEARCH METHODOLOGY & SCOPE
7.1. RESEARCH SCOPE & DELIVERABLES
7.1.1. OBJECTIVES OF STUDY
7.1.2. SCOPE OF STUDY
7.2. SOURCES OF DATA
7.2.1. PRIMARY DATA SOURCES
7.2.2. SECONDARY DATA SOURCES
7.3. RESEARCH METHODOLOGY
7.3.1. EVALUATION OF PROPOSED MARKET
7.3.2. IDENTIFICATION OF DATA SOURCES
7.3.3. ASSESSMENT OF MARKET DETERMINANTS
7.3.4. DATA COLLECTION
7.3.5. DATA VALIDATION & ANALYSIS
TABLE 1: EUROPE PRECISION MEDICINE MARKET, COUNTRY OUTLOOK, 2021-2028 (IN $ MILLION)
TABLE 2: MARKET ATTRACTIVENESS INDEX
TABLE 3: VENDOR LANDSCAPE
TABLE 4: LIST OF CONTRACTS & PARTNERSHIPS
TABLE 5: LIST OF BUSINESS EXPANSIONS & DIVESTITURES
TABLE 6: LIST OF ACQUISITIONS & MERGERS
TABLE 7: LIST OF NEW PRODUCT LAUNCHES
TABLE 8: EUROPE PRECISION MEDICINE MARKET, BY APPLICATION, 2021-2028 (IN $ MILLION)
TABLE 9: EUROPE PRECISION MEDICINE MARKET, BY COMPONENT, 2021-2028 (IN $ MILLION)
TABLE 10: EUROPE APPLIED SCIENCE MARKET, BY TYPE, 2021-2028 (IN $ MILLION)
TABLE 11: EUROPE GENOMICS MARKET, BY TYPE, 2021-2028 (IN $ MILLION)
TABLE 12: EUROPE PRECISION THERAPEUTICS MARKET, BY TYPE, 2021-2028 (IN $ MILLION)
TABLE 13: EUROPE PRECISION DIAGNOSTICS MARKET, BY TYPE, 2021-2028 (IN $ MILLION)
TABLE 14: EUROPE MOLECULAR DIAGNOSTICS MARKET, BY TYPE, 2021-2028 (IN $ MILLION)
TABLE 15: EUROPE MEDICAL IMAGING MARKET, BY TYPE, 2021-2028 (IN $ MILLION)
TABLE 16: EUROPE DIGITAL HEALTH AND INFORMATION TECHNOLOGY MARKET, BY TYPE, 2021-2028 (IN $ MILLION)
TABLE 17: EUROPE PRECISION MEDICINE MARKET, BY COUNTRY, 2021-2028 (IN $ MILLION)
FIGURE 1: EUROPE PRECISION MEDICINE MARKET, COUNTRY OUTLOOK, 2021-2028 (IN $ MILLION)
FIGURE 2: EUROPE PRECISION MEDICINE MARKET, BY APPLICATION, 2020 & 2028
FIGURE 3: EUROPE PRECISION MEDICINE MARKET, BY ONCOLOGY, 2021-2028 (IN $ MILLION)
FIGURE 4: EUROPE PRECISION MEDICINE MARKET, BY INFECTIOUS DISEASES, 2021-2028 (IN $ MILLION)
FIGURE 5: EUROPE PRECISION MEDICINE MARKET, BY NEUROLOGY/PHYSIATRY, 2021-2028 (IN $ MILLION)
FIGURE 6: EUROPE PRECISION MEDICINE MARKET, BY CARDIOVASCULAR, 2021-2028 (IN $ MILLION)
FIGURE 7: EUROPE PRECISION MEDICINE MARKET, BY LIFESTYLE AND ENDOCRINOLOGY, 2021-2028 (IN $ MILLION)
FIGURE 8: EUROPE PRECISION MEDICINE MARKET, BY GASTROENTEROLOGY, 2021-2028 (IN $ MILLION)
FIGURE 9: EUROPE PRECISION MEDICINE MARKET, BY OTHER APPLICATIONS, 2021-2028 (IN $ MILLION)
FIGURE 10: EUROPE PRECISION MEDICINE MARKET, BY COMPONENT, 2020 & 2028
FIGURE 11: EUROPE PRECISION MEDICINE MARKET, BY APPLIED SCIENCE, 2021-2028 (IN $ MILLION)
FIGURE 12: EUROPE APPLIED SCIENCE MARKET, BY GENOMICS, 2021-2028 (IN $ MILLION)
FIGURE 13: EUROPE GENOMICS MARKET, BY PCR, 2021-2028 (IN $ MILLION)
FIGURE 14: EUROPE GENOMICS MARKET, BY PM NGS, 2021-2028 (IN $ MILLION)
FIGURE 15: EUROPE GENOMICS MARKET, BY GENOME EDITING, 2021-2028 (IN $ MILLION)
FIGURE 16: EUROPE GENOMICS MARKET, BY OTHER GENOMICS TECHNOLOGIES, 2021-2028 (IN $ MILLION)
FIGURE 17: EUROPE APPLIED SCIENCE MARKET, BY PHARMACOGENOMICS, 2021-2028 (IN $ MILLION)
FIGURE 18: BIOMARKERS ROLE IN PHARMACOGENOMICS
FIGURE 19: EUROPE APPLIED SCIENCE MARKET, OTHER APPLIED SCIENCES, 2021-2028 (IN $ MILLION)
FIGURE 20: EUROPE PRECISION MEDICINE MARKET, BY PRECISION THERAPEUTICS, 2021-2028 (IN $ MILLION)
FIGURE 21: EUROPE PRECISION THERAPEUTICS MARKET, BY CLINICAL TRIALS, 2021-2028 (IN $ MILLION)
FIGURE 22: EUROPE PRECISION THERAPEUTICS MARKET, BY CELL THERAPY, 2021-2028 (IN $ MILLION)
FIGURE 23: EUROPE PRECISION THERAPEUTICS MARKET, BY DRUG DISCOVERY AND RESEARCH, 2021-2028 (IN $ MILLION)
FIGURE 24: EUROPE PRECISION THERAPEUTICS MARKET, BY GENE THERAPY, 2021-2028 (IN $ MILLION)
FIGURE 25: EUROPE PRECISION MEDICINE MARKET, BY PRECISION DIAGNOSTICS, 2021-2028 (IN $ MILLION)
FIGURE 26: EUROPE PRECISION DIAGNOSTICS MARKET, BY MOLECULAR DIAGNOSTICS, 2021-2028 (IN $ MILLION)
FIGURE 27: EUROPE MOLECULAR DIAGNOSTICS MARKET, BY NON-INVASIVE PRENATAL TESTING (NIPT), 2021-2028 (IN $ MILLION)
FIGURE 28: EUROPE MOLECULAR DIAGNOSTICS MARKET, BY COMPANION DIAGNOSTICS, 2021-2028 (IN $ MILLION)
FIGURE 29: EUROPE MOLECULAR DIAGNOSTICS MARKET, BY LIQUID BIOPSY, 2021-2028 (IN $ MILLION)
FIGURE 30: EUROPE MOLECULAR DIAGNOSTICS MARKET, BY OTHER MOLECULAR DIAGNOSTICS, 2021-2028 (IN $ MILLION)
FIGURE 31: EUROPE PRECISION DIAGNOSTICS MARKET, BY MEDICAL IMAGING, 2021-2028 (IN $ MILLION)
FIGURE 32: EUROPE MEDICAL IMAGING MARKET, BY IMAGING ANALYTICS, 2021-2028 (IN $ MILLION)
FIGURE 33: EUROPE MEDICAL IMAGING MARKET, BY IMAGING COMPUTER-AIDED DETECTION (CADX), 2021-2028 (IN $ MILLION)
FIGURE 34: EUROPE PRECISION MEDICINE MARKET, BY DIGITAL HEALTH AND INFORMATION TECHNOLOGY, 2021-2028 (IN $ MILLION)
FIGURE 35: EUROPE DIGITAL HEALTH AND INFORMATION TECHNOLOGY MARKET, BY CLINICAL DECISION SUPPORT SYSTEMS (CDSS), 2021-2028 (IN $ MILLION)
FIGURE 36: EUROPE DIGITAL HEALTH AND INFORMATION TECHNOLOGY MARKET, BY BIG DATA ANALYTICS, 2021-2028 (IN $ MILLION)
FIGURE 37: EUROPE DIGITAL HEALTH AND INFORMATION TECHNOLOGY MARKET, BY IT INFRASTRUCTURE, 2021-2028 (IN $ MILLION)
FIGURE 38: EUROPE DIGITAL HEALTH AND INFORMATION TECHNOLOGY MARKET, BY GENOMICS INFORMATICS, 2021-2028 (IN $ MILLION)
FIGURE 39: EUROPE DIGITAL HEALTH AND INFORMATION TECHNOLOGY MARKET, BY IN-SILICO INFORMATICS, 2021-2028 (IN $ MILLION)
FIGURE 40: EUROPE DIGITAL HEALTH AND INFORMATION TECHNOLOGY MARKET, BY MOBILE HEALTH, 2021-2028 (IN $ MILLION)
FIGURE 41: GERMANY PRECISION MEDICINE MARKET 2021-2028 (IN $ MILLION)
FIGURE 42: FRANCE PRECISION MEDICINE MARKET 2021-2028 (IN $ MILLION)
FIGURE 43: UNITED KINGDOM PRECISION MEDICINE MARKET 2021-2028 (IN $ MILLION)
FIGURE 44: ITALY PRECISION MEDICINE MARKET 2021-2028 (IN $ MILLION)
FIGURE 45: RUSSIA PRECISION MEDICINE MARKET 2021-2028 (IN $ MILLION)
FIGURE 46: SPAIN PRECISION MEDICINE MARKET 2021-2028 (IN $ MILLION)
FIGURE 47: REST OF EUROPE PRECISION MEDICINE MARKET 2021-2028 (IN $ MILLION)